Too often, recruiters are more clear on what a position will “do” rather than what it will “achieve”.Outlining tasks and responsibilities takes priority over goals and impact.But to attract top talent, you need to define and explain what success looks…
HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Wholesalers Must Revamp Biz Model to Cope with Change in Sales Mix: JPWA Chief
January 14, 2015
-
REGULATORY MHLW Calls for Revision of Package Inserts for SGLT-2 Inhibitors
January 13, 2015
-
ORGANIZATION Price Grouping Rule Triggered “Distortion” in Generic Market: JGA President
January 9, 2015
-
REGULATORY 30% R&D Tax Deduction Cap Could Be Secured with Open Innovation Tax Break: Economic Affairs Division
January 8, 2015
-
REGULATORY Public Trust Indispensable for Industry Development: Mr Futagawa of Health Policy Bureau
January 7, 2015
-
REGULATORY Pharmaceutical and Food Safety Bureau to Promote Prescription-to-OTC Switches Based on Industry Opinions
January 6, 2015
-
ORGANIZATION FPMAJ Chairman Wishes for Good Environment for Drug Innovation in 2015
January 1, 2015
-
TRENDS ARBs at a Turning Point: Inroads by Generics to Lead to Gradual Decline in Sales
December 26, 2014
-
REGULATORY LDP Study Group Shows Sense of Crisis over Reduction of R&D Tax Deduction Cap
December 25, 2014
-
ORGANIZATION FPMAJ “Hasn’t Given Up” on Maintenance of 30% R&D Tax Deduction Cap: Chairman
December 24, 2014
-
ORGANIZATION EFPIA Japan Chairman Calls for More Rewards for Innovation
December 22, 2014
-
BUSINESS Takeda Names Sanofi’s Plump as New R&D Head
December 19, 2014
-
BUSINESS Daiichi Sankyo Looks to Bring Annual 8-10 Projects into Clinical Phase, Open Innovation Key to Success: R&D Execs
December 18, 2014
-
BUSINESS CRO Intellim to Collaborate with Indian Firm for CDISC
December 18, 2014
-
REGULATORY LDP Tax Panel Execs Eye Slight Cut of R&D Tax Deduction Cap
December 17, 2014
-
BUSINESS Battle Begins for Blopress Generics
December 16, 2014
-
REGULATORY LDP Healthcare Big Names Cruise to Victory in Lower House Poll
December 15, 2014
-
REGULATORY Outline of New Global Clinical Trial Guidelines Agreed On at ICH Confab in Lisbon
December 12, 2014
-
REGULATORY Elplat, Elaspol Generics to Join NHI Price List on Dec. 12
December 11, 2014
-
REGULATORY Annual NHI Price Cuts Draw Fire from All Sides at Ryukaikon Council
December 10, 2014
ページ
Pharmaceutical companies are giving high marks to Japan’s drug pricing reform for FY2024. According to a survey conducted by Jiho, 51% of all respondents expressed a positive opinion of the reform, saying that they were “somewhat satisfied” with it. The…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…